Genome-wide association study on differentiated thyroid cancer

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 10, 2013, Pages

  Köhler, Aleksandra ^a   Chen, Bowang ^a   Gemignani, Federica ^b   Elisei, Rossella ^b   Romei, Cristina ^b   Figlioli, Gisella ^b   Cipollini, Monica ^b   Cristaudo, Alfonso ^b   Bambi, Franco ^c   Hoffmann, Per ^d,e,f   Herms, Stefan ^d,e,f   Kalemba, Michał ^g   Kula, Dorota ^g   Harris, Shelley ^h   Broderick, Peter ^h   Houlston, Richard ^h   Pastor, Susana ^i,j   Marcos, Ricard ^i,j   Velázquez, Antonia ^i,j   Jarzab, Barbara ^g   Hemminki, Kari ^a,k   Landi, Stefano ^b   Försti, Asta ^a,k   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF BONN   (Germany)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f UNIVERSITY OF BASEL   (Switzerland)

^g INSTITUTE OF ONCOLOGY   (Poland)

^h INSTITUTE OF CANCER RESEARCH   (United Kingdom)

ⁱ UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^j CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^k LUND UNIVERSITY   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; DIRC3; DISEASE PREDISPOSITION; FEMALE; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; THYROID NEOPLASMS;

EID: 84885235141     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1941     Document Type: Article

References (29)

1. Agate L, Lorusso L, Elisei R. New and old knowledge on differentiated thyroid cancer epidemiology and risk factors. J Endocrinol Invest. 2012; 35: 3-9.
2. Leenhardt L, Grosclaude P, Chérié-Challine L; Thyroid Cancer Committee. Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid. 2004; 14: 1056-1060.
3. Li N, Du XL, Reitzel L.R., Xu L., Sturgis EM Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: reviewofincidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008. Thyroid. 2013; 23: 103-110.
4. DeLellis RA. Pathology and genetics of thyroid carcinoma. J Surg Oncol. 2006; 94: 662-669.
5. Cardis E, Kesminiene A, Ivanov V., et al Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst. 2005; 97: 724-732.
6. Hemminki K, Eng C, Chen B. Familial risks for nonmedullary thyroid cancer. J Clin Endocrinol Metab. 2005; 90: 5747-5753.
7. Hemminki K, Sundquist J, Lorenzo Bermejo J. Familial risks for cancer as the basis for evidence-based clinical referral and counseling. Oncologist. 2008; 13: 239-247.
8. Nosé V. Familial non-medullary thyroid carcinoma: an update. Endocr Pathol. 2008; 19: 226-240.
9. Bonora E, Tallini G, Romeo G. Genetic predisposition to familial nonmedullary thyroid cancer: an update of molecular findings and state-of-the-art studies. J Oncol. 2010; 2010: 385206.
10. Canzian F, Amati P, Harach H.R., et al A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet. 1998; 63: 1743-1748.
11. Malchoff CD, Sarfarazi M, Tendler B., et al Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab. 2000; 85: 1758-1764.
12. McKay JD, Lesueur F, Jonard L., et al. Localization of asusceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet. 2001; 69: 440-446.
13. He H, Nagy R, Liyanarachchi S., et al A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24. Cancer Res. 2009; 69: 625-631.
14. Gudmundsson J, Sulem P, Gudbjartsson D.F., et al. Commonvariants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet. 2009; 41: 460-464.
15. Takahashi M, Saenko VA, Rogounovitch T.I., et al The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum Mol Genet. 2010; 19: 2516-2523.
16. Gudmundsson J, Sulem P, Gudbjartsson D.F., et al Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat Genet. 2012; 44: 319-322.
17. Penegar S, Wood W, Lubbe S., et al National study of colorectal cancer genetics. Br J Cancer. 2007; 97: 1305-1309.
18. Bodmer D, Schepens M, Eleveld M.J., Schoenmakers EF, Geurts van Kessel A. Disruption of a novel gene, DIRC3, and expression of DIRC3-HSPBAP1 fusion transcripts in a case of familial renal cell cancer and t(2; 3)(q35;q21). Genes Chromosomes Cancer. 2003; 38: 107-116.
19. Petek E, Windpassinger C, Vincent J.B., et al Disruption of a novel gene (IMMP2L) by a breakpoint in 7q31 associated with Tourette syndrome. Am J Hum Genet. 2001; 68: 848-858.
20. Maestrini E, Pagnamenta AT, Lamb J.A., et al; IMGSAC. 2010 High-density SNP association study and copy number variation analysis of the AUTS1 and AUTS5loci implicate the IMMP2L-DOCK4 gene region in autism susceptibility. Mol Psychiatry. 15: 954-968.
21. Bertin J, Guo Y, Wang L., et al CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-kappa B. J Biol Chem. 2000; 275: 41082-41086.
22. Nakamura S, Nakamura S, Matsumoto T., et al Overexpression of caspase recruitment domain (CARD) membrane-associated guany-late kinase 1 (CARMA1) and CARD9 in primary gastric B-cell lymphoma. Cancer. 2005; 104: 1885-1893.
23. Repplinger D, Bargren A, Zhang Y.W., Adler JT, Haymart M, Chen H. Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer? J Surg Res. 2008; 150: 49-52.
24. Lopez Herraez D., Bauchet M, et al Genetic variation and recent positive selection in worldwide human populations: evidence from nearly 1 million SNPs. PloS one. 2009; 4: e7888.
25. McEvoy BP, Montgomery GW, McRae A.F., et al Geographical structure and differential natural selection among North European populations. Genome Res. 2009; 19: 804-814.
26. Novembre J, Johnson T, Bryc K., et al Genes mirror geography within Europe. Nature. 2008; 456: 98-101.
27. Nagpal S, Patel S, Asano A.T., Johnson AT, Duvic M, Chandraratna RA. Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin. J Invest Dermatol. 1996; 106: 269-274.
28. Jing C, El-Ghany MA, Beesley C., et al Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity. J Natl Cancer Inst. 2002; 94: 482-490.
29. Zhang J, Liu L, Pfeifer GP Methylation of the retinoid response gene TIG1 in prostate cancer correlates with methylation of the retinoic acid receptor beta gene. Oncogene. 2004; 23: 2241-2249.